Adherence to Exclusive Enteral Nutrition in Patients With Crohn's Disease
NCT ID: NCT04933214
Last Updated: 2021-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
131 participants
OBSERVATIONAL
2021-05-12
2021-12-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nutritional Status and Body Composition of Adult Patients With Crohn's Disease
NCT04915911
Predictors Favoring the Role of Exclusive Enteral Nutrition in Active Crohn's Disease
NCT02942511
Exclusive Enteral Nutrition for Remissionof Crohn's Diseases After Surgery
NCT05214430
Based on the Special Disease Management of Crohn's Disease Diet Studies
NCT04976491
Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's Disease
NCT04135027
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The main inclusion criteria were as follows: had diagnosed CD more than 3 months; had EEN in the past 6 months; were at least 18 years old; agreed to participate in this study.
Exclusion Criteria:
* The exclusion criteria were received treatment from mental health professionals due to any mental or cognitive impairment; suffered from other serious diseases, such as heart, brain, lung, liver and kidney dysfunction; severe infection, anemia, cachexia or other serious complications were found.
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yan Chen
Role: STUDY_DIRECTOR
2ndAffiliated Hospital, School of Medicine, Zhejiang University, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
2ndAffiliated Hospital, School of Medicine, Zhejiang University, China
Zhejiang, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-0324
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.